4.6 Article

Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding

Nicolas H. Thurin et al.

Summary: The ConcePTION project aims to reduce uncertainty about the safety of medication use in pregnancy and breastfeeding by building an ecosystem and leveraging a common data model. The model enables European data sources to contribute to major projects and facilitate effective deployment of distributed analytics.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Article Multidisciplinary Sciences

Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: A nationwide population-based cohort study

Yin-Hsi Chang et al.

Summary: This study compared the risk of major arterial thromboembolic events and glaucoma between intravitreal aflibercept injection and intravitreal ranibizumab injection. The results showed no significant differences in the risk of major ATEs and glaucoma between the two treatments.

PLOS ONE (2022)

Review Ophthalmology

VEGFR1 signaling in retinal angiogenesis and microinflammation

Akiyoshi Uemura et al.

Summary: VEGFR1 and its ligands play important roles in angiogenesis and microinflammatory cascades within the retina, but the mechanisms of their actions remain unclear, the competition for receptor binding and heterodimerization complicates the understanding of their relative contributions.

PROGRESS IN RETINAL AND EYE RESEARCH (2021)

Article Ophthalmology

Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial

Ahmad A. Aref et al.

Summary: This study investigated IOP related events in participants receiving intravitreal anti-VEGF injections for up to 60 months, with a small percentage experiencing elevated IOP over baseline.

JAMA OPHTHALMOLOGY (2021)

Review Ophthalmology

Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations

Ariana M. Levin et al.

Summary: Published studies indicate that transient intraocular pressure (IOP) spikes are common after intravitreal injections of anti-vascular endothelial growth factor agents, but there is currently no standard of care for preventing this phenomenon. Challenges exist in determining the impact of postinjection IOP elevation on the health of retinal ganglion cells, particularly in the presence of comorbidities with retinal and glaucoma pathology.

JOURNAL OF GLAUCOMA (2021)

Article Ophthalmology

Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study

Michele Augsburger et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)

Review Ophthalmology

The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases

Tine Van Bergen et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2019)

Article Ophthalmology

Changes in intraocular pressure in study and fellow eyes in the IVAN trial

Alexander J. E. Foss et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2016)

Article Cell Biology

Inhibition of placental growth factor improves surgical outcome of glaucoma surgery

Tine Van Bergen et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)

Article Ophthalmology

Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans

Tim U. Krohne et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)

Article Ophthalmology

Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents

Travis J. Good et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2011)